AJOVY: FDA approves new CGRP monoclonal antibody!

On September 14th, the FDA approved Ajovy for migraine prevention This is the 2nd antibody to be approved specifically for the prevention of migraine. Indeed, it is a very exciting time for migraine research, migraine treatment, for migraine patients and care providers!
Ajovy is intended for migraine prevention in the form of monthly injections, in the case of Ajovy, there is a once every 3 month protocol that was approved. Also, tolerability by the patient has shown to be very good!.
This might be the right medication for you. Make an appointment to see our headache specialist to talk about migraine treatment options. We have Ajovy $0 copay cards available for our patients. During your consultation, inquire about eligibility! We are so excited to speak with you!